Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 136 | -113,724 | -250,157 | -65,578 | -89,127 |
| Depreciation Amortization | 6,881 | 7,146 | 8,022 | 8,971 | 7,575 |
| Accounts receivable | -2,068 | N/A | N/A | 9,387 | -7,602 |
| Accounts payable and accrued liabilities | -2,940 | -11,578 | 2,203 | 9,362 | -1,159 |
| Other Working Capital | -65,509 | -58,977 | -18,391 | 41,530 | -23,197 |
| Other Operating Activity | -85,109 | 59,779 | 29,507 | 3,016 | 19,900 |
| Operating Cash Flow | $-148,609 | $-117,354 | $-228,816 | $6,688 | $-93,610 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -380 | -7,975 | -9,821 | -9,566 | -591 |
| Net Acquisitions | 141,272 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -4,426 | -48,221 | -95,971 | -218,284 |
| Sale Of Investment | N/A | 22,983 | 140,470 | 169,625 | 59,984 |
| Other Investing Activity | 1,401 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $142,293 | $10,582 | $82,428 | $64,088 | $-158,891 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 103,378 | 27,606 | N/A | N/A |
| Debt Repayment | -127,905 | -52,860 | -1,907 | -948 | 0 |
| Common Stock Issued | 24,017 | 21,187 | 103,903 | 2,126 | 283,524 |
| Other Financing Activity | 13,516 | 0 | 0 | 0 | 19,900 |
| Financing Cash Flow | $-90,372 | $71,705 | $129,602 | $1,178 | $303,424 |
| Exchange Rate Effect | -1 | 2 | -1 | -1 | 0 |
| Beginning Cash Position | 136,150 | 171,215 | 188,002 | 116,049 | 65,126 |
| End Cash Position | 39,461 | 136,150 | 171,215 | 188,002 | 116,049 |
| Net Cash Flow | $-96,689 | $-35,065 | $-16,787 | $71,954 | $50,923 |
| Free Cash Flow | |||||
| Operating Cash Flow | -148,609 | -117,354 | -228,816 | 6,688 | -93,610 |
| Capital Expenditure | -380 | -7,975 | -9,821 | -9,566 | -591 |
| Free Cash Flow | -148,989 | -125,329 | -238,637 | -2,878 | -94,201 |